Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxercalciferol vs Calcitriol for Lowering PTH in Hemodialysis Patients
NCT07640347Not yet recruiting
- Sponsor
- Chattogram Medical College
- Start
- Jul 2026
- Primary completion
- May 2027
01
Overview
Randomised trial of doxercalciferol in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Chattogram Medical College. Primary endpoint: Change in serum Parathyroid Hormone levels at 12 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT07640347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640347.